CG
TMO icon

Cynosure Group’s Thermo Fisher Scientific TMO Stock Holding History

Cynosure Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-979
Closed -$567K – 444
2025
Q4 		$567K Sell
979
-1,362
-58% -$770K 0.06% 121
2025
Q3 		$1.14M Sell
2,341
-5,293
-69% -$2.46M 0.12% 63
2025
Q2 		$3.1M Buy
7,634
+6,177
+424% +$2.58M 0.35% 35
2025
Q1 		$725K Sell
1,457
-3,329
-70% -$1.8M 0.1% 100
2024
Q4 		$2.49M Buy
4,786
+3,131
+189% +$1.72M 0.37% 36
2024
Q3 		$1.02M Buy
1,655
+209
+14% +$124K 0.15% 72
2024
Q2 		$800K Buy
1,446
+156
+12% +$89.4K 0.13% 96
2024
Q1 		$750K Sell
1,290
-551
-30% -$309K 0.13% 81
2023
Q4 		$977K Buy
1,841
+231
+14% +$112K 0.18% 97
2023
Q3 		$815K Buy
1,610
+87
+6% +$46.4K 0.25% 81
2023
Q2 		$795K Buy
+1,523
New +$822K 0.24% 86
2022
Q3 		– Sell
-641
Closed -$348K – 44
2022
Q2 		$348K Buy
+641
New +$353K 0.34% 30
2020
Q2 		– Sell
-1,467
Closed -$416K – 58
2020
Q1 		$416K Sell
1,467
-259
-15% -$81.7K 0.3% 37
2019
Q4 		$561K Hold
1,726
– – 0.3% 31
2019
Q3 		$503K Sell
1,726
-610
-26% -$175K 0.27% 32
2019
Q2 		$686K Buy
+2,336
New +$643K 0.32% 32

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cynosure Group's TMO Position: Q1 2026 in Review

Cynosure Group sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 979 shares — an estimated $567K sold.

Cynosure Group first reported a position in TMO in Q2 2019 and held it in 16 quarters. The position peaked at $3.1M in Q2 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Cynosure Group reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 979 Thermo Fisher Scientific shares in Q1 2026, an estimated $567K.
  • Cynosure Group first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 16 quarters.
  • Cynosure Group's Thermo Fisher Scientific position peaked at $3.1M in Q2 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.